Latest Financial Disclosure News

Genesis Resources has completed its acquisition of full ownership of the Plavica JV in North Macedonia and is progressing environmental studies and exploration planning for multiple Australian tenements ahead of 2025 drilling campaigns.

Tigers Realm Coal’s planned divestment of its Russian subsidiaries has hit significant regulatory roadblocks, resulting in a reduced sale price, increased exit tax, and suspension from ASX trading.

Bellevue Gold Limited reported modest operating cash flow for Q1 2025, heavy investment in development, and a significant post-quarter capital raise to strengthen its financial position.

Mineral Resources Limited posted a substantial $809 million loss for the half-year ending December 2024, driven by lower revenues and significant impairment charges, notably at its Bald Hill lithium project. The company also announced no interim dividend as it focuses on liquidity and operational transitions.

Ignite Limited has announced a fully franked ordinary dividend of AUD 0.035 per share, payable on March 21, 2025, signaling steady shareholder returns for the half-year ending December 2024.

Sequoia Financial Group will release its half-year FY25 financial results on 27 February 2025, accompanied by an investor webinar hosted by its CEO and CFO.

Dexus (ASX: DXS) reports a statutory net profit of $10.3 million for the half-year ending December 2024, rebounding from a significant loss last year, while navigating challenges from higher interest rates and lower trading profits.

Ramelius Resources will release its half-year financial results for FY25 on 21 February, accompanied by a detailed investor conference call.

Norwood Systems has extended its cash drawdown facility for the sixth time, increasing the principal to $732,189.69 and pushing the repayment deadline to late February 2025.

Bapcor Limited will announce its half-year financial results for the period ending December 2024 on 26 February, with a live briefing hosted by its top executives.

Suncorp Group Limited has delivered a strong half-year performance for the period ending December 31, 2024, with significant growth in revenue and net profit, while navigating the ongoing return of proceeds from its Suncorp Bank sale.

SomnoMed Limited prepares to unveil its H1FY25 financial results on February 28, 2025, accompanied by a live investor presentation and Q&A session. The company remains a global leader in sleep apnea treatment solutions.